EUVIMEDEUVIMED entdecken
Crossref

Elucidating the molecular mechanism of Bazhen decoction in the treatment of liver cancer: an integrated approach using network pharmacology, cancer databases, molecular docking, and experimental validation

Feng Wang, Yi Wang, Qi Wang, Yuchen Liu, Haroon Ur Rashid, Jingting Feng, Haiyan Dong, Panke Zeng iD

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgaf129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Feng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, P.R. China. Hauptthemen laut MEDLINE: Liver Neoplasms, Drugs, Chinese Herbal, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: First Affiliated Hospital of Xi'an Jiaotong University, research project on high quality development of Hospital pharmacy, First Affiliated Hospital of Xi’an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the Bazhen decoction (BZD) mechanism in the treatment of liver cancer (LC).

Methods

Integrative approach combining network pharmacology, HPLC, molecular docking, public cancer databases, and MTT colorimetric assay to elucidate the pharmacological mechanisms of BZD against LC. Key findings We identified 647 common targets between BZD and LC, with PPI analysis revealing SRC, PIK3CA, AKT1, HSP90AA1, and STAT3 as core targets. KEGG pathway analysis further highlighted PI3K-AKT, MAPK, HIF-1, and Rap1 signaling pathways as critical mechanisms mediating BZD’s therapeutic effects. Notably, validation using cancer databases showed that many core targets exhibit differential messenger RNA (mRNA) and protein expression between LC and normal tissues, with their expression levels significantly associated with the overall survival of LC patients. Molecular docking analysis revealed strong binding affinities between the majority of core compounds and their corresponding core targets. HPLC analysis was performed using neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, ferulic acid, and senkyunolide I as reference standards. MTT assays confirmed that BZD significantly inhibited the proliferation of HepG2 and Huh7 cells in a time- and dose-dependent manner.

Conclusions

BZD exerts anti-LC effects through multi-target regulation, particularly involving AKT1, PIK3CA, SRC, and HSP90AA1, as well as suppression of the PI3K-AKT signaling pathway. These findings provide a mechanistic basis for its potential clinical application in LC therapy and warrant further in vivo investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsDrugs, Chinese HerbalAntineoplastic Agents, PhytogenicHumansMolecular Docking SimulationNetwork PharmacologySignal TransductionProto-Oncogene Proteins c-aktCell ProliferationHep G2 CellsCell Line, Tumor

Stichwörter der Autor:innen

Bazhen decoctionPI3K/Akt signaling pathwayliver cancermolecular dockingnetwork pharmacology

Substanzen

Drugs, Chinese HerbalAntineoplastic Agents, PhytogenicProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, P.R. China.
  • Center for Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, Pelotas, RS 96010-610, Brazil.

ORCID-Profile: Panke Zeng

Förderung

  • First Affiliated Hospital of Xi'an Jiaotong University
  • research project on high quality development of Hospital pharmacy
  • First Affiliated Hospital of Xi’an Jiaotong University

Zitieren

APA

Wang, F., Wang, Y., Wang, Q., Liu, Y., Rashid, H. U., Feng, J., Dong, H., & Zeng, P. (2026). Elucidating the molecular mechanism of Bazhen decoction in the treatment of liver cancer: an integrated approach using network pharmacology, cancer databases, molecular docking, and experimental validation. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf129

Vancouver

Wang F, Wang Y, Wang Q, Liu Y, Rashid HU, Feng J, et al. Elucidating the molecular mechanism of Bazhen decoction in the treatment of liver cancer: an integrated approach using network pharmacology, cancer databases, molecular docking, and experimental validation. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf129

BibTeX
@article{Wang2026,
  author = {Wang, Feng and Wang, Yi and Wang, Qi and Liu, Yuchen and Rashid, Haroon Ur and Feng, Jingting and Dong, Haiyan and Zeng, Panke},
  title = {Elucidating the molecular mechanism of Bazhen decoction in the treatment of liver cancer: an integrated approach using network pharmacology, cancer databases, molecular docking, and experimental validation},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgaf129}
}
Kostenlos starten →